share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 Rodgers Richard J
美股SEC公告 ·  01/03 05:57

牛牛AI助理已提取核心訊息

On October 29, 2024, Rodgers Richard J, associated with Novavax, acquired 3,800 shares of Common Stock at $0 per share through the exercise or conversion of a derivative security. This transaction was reported as completed.Following the acquisition, Rodgers Richard J's direct ownership of Novavax Common Stock increased to 14,270 shares. The transaction was executed under the code 'M', indicating it resulted from the exercise or conversion of a derivative security rather than an open market purchase.
On October 29, 2024, Rodgers Richard J, associated with Novavax, acquired 3,800 shares of Common Stock at $0 per share through the exercise or conversion of a derivative security. This transaction was reported as completed.Following the acquisition, Rodgers Richard J's direct ownership of Novavax Common Stock increased to 14,270 shares. The transaction was executed under the code 'M', indicating it resulted from the exercise or conversion of a derivative security rather than an open market purchase.
在2024年10月29日,與諾瓦瓦克斯醫藥相關的羅傑斯·理查德·J通過行使或轉換衍生證券以每股0美元的價格收購了3,800股普通股。該交易已報告完成。在收購後,羅傑斯·理查德·J對諾瓦瓦克斯醫藥普通股的直接持有量增加到14,270股。該交易的執行代碼爲'M',表明這是由於行使或轉換衍生證券,而不是公開市場購買。
在2024年10月29日,與諾瓦瓦克斯醫藥相關的羅傑斯·理查德·J通過行使或轉換衍生證券以每股0美元的價格收購了3,800股普通股。該交易已報告完成。在收購後,羅傑斯·理查德·J對諾瓦瓦克斯醫藥普通股的直接持有量增加到14,270股。該交易的執行代碼爲'M',表明這是由於行使或轉換衍生證券,而不是公開市場購買。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。